Journal of Biomedical and Clinical Research 16(1): 62-65, doi: 10.2478/jbcr-2023-0009
Clinical Case of a Patient with Extranodal Diffuse Large B-Cell Lymphoma and Surgical Complications
expand article infoRalitsa G. Ilieva, Doroteya K. Todorieva-Todorova, Ivaylo G. Hristov, Vasilena P. Tsintsarska
© Ralitsa Ilieva, Doroteya Todorieva-Todorova, Ivaylo Hristov, Vasilena Tsintsarska.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits to copy and distribute the article for non-commercial purposes, provided that the article is not altered or modified and the original author and source are credited.
Citation: Ilieva RG, Todorieva-Todorova DK, Hristov IG, Tsintsarska VP (2023) Clinical Case of a Patient with Extranodal Diffuse Large B-Cell Lymphoma and Surgical Complications. Journal of Biomedical and Clinical Research 16(1): 62-65. https://doi.org/10.2478/jbcr-2023-0009
Open Access
Abstract
Diffuse large B-cell lymphoma (DLBCL) is one of the most common types of non-Hodgkin lymphoma in adults. In most of the cases a complete remission is possible to obtain by applying conventional immunochemotherapy (rituximab in combination with cyclophosphamide, doxorubicin, vincristine, methylprednisolone or R-CHOP). Its effect depends on some risk factors, cellular origin of the lymphoma and to some extend – the localization when extranodal involvement is confirmed. We present the case of a patient with DLBCL of small intestine and non-specific clinical manifestation. Following treatment with standard therapy R-CHOP patient fail to achieve disease response and gastrointestinal track (GIT) complications were registered.
Keywords
intestinal lymphoma, surgical complications, therapy